BioMarin Pharmaceutical Inc. buy Guggenheim
Start price
06.08.25
/
50%
€52.34
Target price
06.08.26
€91.63
Performance (%)
-11.16%
Price
10.04.26
€46.50
Summary
This prediction is currently active. The prediction for BioMarin Pharmaceutical Inc. disappoints with a performance of -11.16%. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -3.367% | -3.367% |
| iShares Core DAX® | 2.554% | -0.112% |
| iShares Nasdaq 100 | 2.742% | -0.470% |
| iShares Nikkei 225® | 6.584% | 3.221% |
| iShares S&P 500 | 1.930% | -0.519% |
Comments by Guggenheim for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at Guggenheim from $101.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by Guggenheim for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€52.18
25.02.26
25.02.26
€72.96
25.02.27
25.02.27
-10.89%
10.04.26
10.04.26
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€85.26
13.09.23
13.09.23
€102.48
13.09.24
13.09.24
-11.56%
14.09.24
14.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€94.17
28.02.23
28.02.23
€117.80
28.02.24
28.02.24
-13.41%
29.02.24
29.02.24